SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " atm " 2,173 found 🔀 AI-powered Shuffle
Curbing Congo’s Ebola outbreak is hampered by unknowns about the virus
Answers to key questions could help public health officials develop Ebola treatments, predict the outbreak’s trajectory and prevent a future one.
Artists and Scientists Partner to Bring Atmospheric Data to Life
In the fluxART project, scientists using eddy covariance to study atmospheric flux partnered with artists to help communicate the “breath of the biosphere.”
This new diabetes pill burns fat without the downsides of Ozempic
Scientists have developed an experimental diabetes and obesity pill that works in a completely different way from drugs like Ozempic. Rather than reducing hunger, it activates metabolism in skeletal muscle, helping lower blood sugar and increase fat burning while preserving muscle mass. Early clinical results suggest the treatment is safe and well tolerated.
Scientists reverse anxiety by fixing a tiny brain circuit
A newly identified group of amygdala neurons appears to play a central role in anxiety and social behavior. Restoring normal activity in this tiny brain circuit reversed anxiety and social deficits in mice, revealing a promising new target for future treatments.
Temple researchers are building AI-powered health care ‘digital twins’ for people with ALS
A digital twin is a virtual representation of patients. Doctors plan to use the program to simulate treatments and therapies.
Red States’ Sound Science Laws Echo Trump Regulatory Overhaul
Republican-led states are following President Donald Trump’s lead and making it harder for their agencies to exceed federal environmental standards.
The science around GLP-1 drugs and cancer is suddenly getting a lot more interesting
Studies released in recent weeks are fueling optimism — and fresh questions — about GLP-1 drugs' potential role in cancer prevention and treatment.
Waiting times for healthcare in Europe: The worst countries ranked
Waiting times for treatment in some European countries can run for years. This has real consequences for patients, experts warn. Euronews Health takes a close look at waiting times across several categories.
Can You Delay Menopause? Experts Explain What's Actually Possible
Trendy treatments like rapamycin and red light therapy claim to delay menopause, but the science behind ovarian aging is complicated.
Records show Atlanta Beltline stabbing suspect received mental health services days before attack
Police records say the treatment came just 12 days before the deadly attack.
Catholic Health CEO Dr. Patrick O'Shaughnessy steps down
Chief Operating Officer Gary Havican will serve as interim president while the hospital system's board conducts a national search.
Power Tee: Installs automatic systems at new Florida entertainment venue
Pine Royale, located in Callahan, Florida, now features Trackman technology, mini-golf and a vibrant social atmosphere alongside its automated driving range.
Hearing loss is bad for the whole body – but new treatments are coming
From dementia to heart attacks, hearing loss has been linked to a wide range of effects across the body, and the condition is on the rise. Fortunately, we're learning how best to safeguard this crucial sense and how we might be able to reverse the damage
How Science Works
The 2nd Weather and Climate Livestream is now underway. It is organized by a group of early-career researchers concerned about declining funding for the field and eager to demonstrate how weather and climate research makes a difference in our lives. Last year’s event was a great success, drawing terrific press coverage including a piece in the NY Times. This year features a strong lineup of talks aimed at a general audience — I highly recommend tuning in. Share I gave a talk yesterday about How Science Works in Three Steps. You can see the short presentation here (I’ve appended a transcript below): And please tune into the livestream here. It runs through tomorrow at 6 pm ET. Thanks for reading The Climate Brink! Subscribe for free to receive new posts and support our work. Subscribe Cleaned up transcript: Thank you, and thanks to everyone tuning in. I want to talk about something I think a lot of people don’t really understand: how science actually works. Arguments over any scientific topic — climate change, vaccines, you name it — revolve around competing claims. For climate change, the claims are: Is the Earth warming? Are humans to blame? What will the impacts be? Over the last 150 years, the scientific community has developed a remarkably robust method for sorting out which claims are true and which aren’t. That method is what I want to walk through. So how does science generate knowledge? If you ask a high schooler, they’ll give you the version they learned in ninth grade: an individual scientist forms a hypothesis, runs an experiment, and draws a conclusion. That’s more or less what happens at the individual level, though in practice it’s more iterative — you design, test, and refine all at once, landing on a slightly different idea each time until you reach a conclusion about whatever hypothesis you’ve ended up with. But this isn’t science. It’s only step one. Any individual scientist can make mistakes — scientists are human. Maybe there’s a bug in the code, maybe there’s an error in the experiment. Just because someone ran an experiment and reached a conclusion doesn’t mean it’s right, and scientists don’t treat a single result as settled truth. Step two is peer review, the first layer of quality control. The scientist writes up what they did and submits it to a journal, which sends the paper to other experts in the field. Those experts judge whether the methods are sound, whether it properly references prior work, and whether the conclusions actually follow from the data. Ask any scientist and they’ll tell you peer review is miserable — the comments come back brutal, often harsh, and you have to revise and resubmit, sometimes multiple times, before an editor finally accepts the paper. Peer review catches an immense amount of bad science, but it can’t catch all of it. Reviewers get sloppy or overworked, they miss obvious mistakes, and they can’t catch hidden errors — a bug in the code, a misread instrument. So a peer-reviewed paper making it into a journal doesn’t mean the paper is right. Nobody treats a single paper as the final word. That’s where step three comes in: the crucible of science. Important results get retested by the broader community. If you publish something interesting, it gets dissected. Sometimes people try to reproduce your work directly but more often they test its implications. If someone claims X is true, and that implies that Y is also true, then scientists will go check Y. If a claim survives this gauntlet long enough, it becomes accepted. That’s how we generate knowledge. Let me give an example: the ozone hole. In 1985 — and I doubt many people watching were around then, but I remember it well — Joe Farman and his colleagues published observations from Antarctica showing that a huge chunk of ozone was disappearing every year. This was shocking because most atmospheric chemists had expected ozone loss to occur at mid-latitudes and high altitudes, not over the South Pole. When scientists see something they don’t understand, they rush to explain it, and several competing hypotheses quickly appeared in the peer-reviewed literature. One pointed to chlorine chemistry from chlorofluorocarbons. A second blamed nitrogen chemistry, possibly driven by solar proton events — meaning the sun was responsible. A third argued it wasn’t chemistry at all but dynamics: winds were carrying naturally low-ozone air from the lower atmosphere up into the stratosphere. Then the community went to work testing which theory could survive the crucible. Aircraft flew into the ozone hole and found no nitrogen, ruling out the nitrogen theory. Measurements showed the air in the polar vortex was descending, not rising — which would bring high-ozone air down, eliminating the dynamics theory. Meanwhile, those same flights measured enormous amounts of chlorine, strongly correlated with exactly the regions where ozone was being destroyed. That became known as the “smoking gun” paper, and it established that chlorine chemistry was the cause. Through this process, a consensus emerged. And it’s worth being clear that this consensus is organic. There’s no vote, no poll, no meeting where it gets decided. Scientists go to conferences, talk to one another, and independently arrived at the same answer. It’s the ultimate free market of ideas. After the consensus was established, the peer-reviewed literature doesn’t even mention the rival theories — it simply takes chlorine chemistry as given. That’s what a consensus looks like. It doesn’t mean every single scientist agrees, but it does mean there’s no longer any legitimate debate. So where can you see what scientists actually think? It’s all in the peer-reviewed literature, which contains the entire historical record of the argument: the discovery, the competing theories, the debate, the testing, and finally the community coalescing around one answer. But there’s a lot of room for misrepresentation. You can dig up an old paper claiming the ozone hole was caused by dynamics and wave it around as if there still was a debate about the cause of the ozone hole — without mentioning that the idea was disproven long ago and that even its own authors no longer believe it. There’s a bigger problem, though: the peer-reviewed literature is written in a language I call “nerd.” It’s extremely hard to read — honestly, some of it is hard for me to follow. It takes graduate students years to work through the literature in a single field, so we can’t expect policymakers or ordinary people to do it. This is where scientific assessments come in. The most famous is the IPCC — the Intergovernmental Panel on Climate Change. The job of an assessment is to read and summarize the peer-reviewed literature, synthesizing what’s settled, what’s been disproven, and what remains genuinely debated. To ensure the assessments accurately summarize the peer-reviewed literature, assessments are written by large teams, which are far less prone to bias than individuals and which dilute the influence of any one scientist with an axe to grind. The teams are deliberately assembled to avoid stacking the deck, and the reports themselves go through multiple rounds of peer review. That rigorous process is exactly why you can trust them and why people consider the IPCC to be the gold standard of what we know about the climate system. An assessment produced through a different process may well not be credible. You can even watch the consensus evolve across assessments. Take the attribution of warming. The 1990 IPCC report said the observed warming was broadly consistent with model predictions but also comparable to natural variability — in other words, we don’t know whether humans are responsible. By 1995, it concluded that the balance of evidence suggested a discernible human influence — a sentence only a committee could write, and one that barely commits to anything. By 2001, most of the warming over the previous 50 years was judged “likely” due to greenhouse gases; by 2007, “very likely”; by 2013, “extremely likely.” The 2023 report says essentially the same as 2013 — there’s not much stronger language available. So, to wrap up: science is our ultimate tool for deciphering the universe — the most successful method we’ve ever developed for determining what’s true and what isn’t. Our understanding is written into the peer-reviewed literature, so if you want to know what scientists think, that’s where to look. And for those of us who don’t speak nerd, scientific assessments are the Rosetta Stone — they translate nerd into English. Let me open the floor to questions. Thank you.
Liverpool legend Sir Kenny Dalglish undergoing treatment for cancer
Sir Kenny Dalglish, one of the greatest and most important figures in Liverpool history, has revealed he is undergoing treatment for cancer. “As my inadvertent social media post has indicated, I am currently undergoing treatment for cancer,” Dalglish said in a statement. Liverpool said “the support, best wishes and love of everyone” at the club were with Dalglish and his family.
Deep Science Ventures and MDC partner to accelerate brain treatments
New collaboration aims to break barriers in brain‑targeted drug discovery
NC leader to encourage mental health treatment without commitment to psychiatric facility
North Carolinians who are suffering from mental illness are sometimes required by judicial officials to undergo treatment at a psychiatric facility — a process that could become more flexible if lawmakers take up a proposal expected Tuesday.
GLP-1 drugs like Ozempic show promise for more than weight loss. But what’s science vs hype?
Ozempic-style drugs have been flagged as possible treatments for cancer, dementia, endo, addiction and more. An expert explains what the evidence really says.
As Ebola Spreads, Scientists Race to Find Vaccines and Treatments
The Bundibugyo virus, a little known type, previously had caused just two small outbreaks. Now it’s at the center of a rapidly widening epidemic in Africa.
A famed folk-rock duo gets the musical treatment at Village Theatre
“We Ain’t Ever Gonna Break Up,” on stage at Village Theatre, loosely maps the tumultuous relationship of obvious analogs Simon & Garfunkel.
In a victory for science advocates, a federal court blocks the Trump administration's push to dismantle NCAR
The decision will delay attempts to break up a center often called the “mothership” of climate science
Baldur's Gate 2 remake reportedly in the works at Wizards of the Coast, with the first game "likely" getting the same treatment too
A rumour regarding Baldur's Gate's future says BG2 is being remade, maybe alongside the original, and co-lead designer Kevin Martens is involved.
Ebola Scares In Brazil, Italy Prompt Fears Of Global Spread (Live Updates)
Protesters in Kenya are protesting plans by the U.S. to build a quarantine and treatment center at Laikipia Air Base.
The Back Pain Myths Patients Still Believe. And What Science Says Instead
Low back pain is one of the most common and misunderstood health problems in the world. Affecting 619 million people globally in 2020, it is now the single leading cause of disability worldwide, according to the World Health Organization (WHO). Yet despite how widespread it is, many people still make care decisions based on myths that can push them toward fear, inactivity, unnecessary treatment, and confusion before they understand what helps.
Confirmed Ebola cases in Congo reach 282 as survivors describe their recoveries
The outbreak remains focused in Congo's eastern Ituri province. Congo has reported over 1,000 suspected cases with the Bundibugyo virus, which has no approved treatment or vaccine.
Healing first: How Mendota Juvenile Treatment Center is succeeding
Mendota Juvenile Treatment Center in Madison provides care to some of Wisconsin's most troubled young people. It plans to expand.
Explore the engine accelerating new cancer treatments at UT San Antonio
See how the university is spurring the path from discovery to care, expanding access to advanced cancer treatments and clinical trials.
How the atmosphere at the FA Cup final epitomised the spirit of togetherness in the women’s game
The gate may have been down appreciably on recent years, but the Wembley showpiece was a celebration - particularly for Manchester City
Gravity Waves From Super Typhoon Sinlaku
Satellites observed striking upper-atmosphere phenomena generated by an intensifying tropical cyclone.
Role of Physical Activity in Obesity Treatment and Cardiometabolic Health
Obesity affects 42% of adults in the United States and is strongly associated with major cardiovascular disease risk factors, including high blood pressure, abnormal cholesterol levels, and insulin resistance, making effective obesity treatment a critical public health priority.
Experimental drug shows promise against deadly pancreatic cancer
A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer.
WHO chief reports 5 Ebola recoveries as new treatment center opens in Congo
Five patients have recovered from a rare type of Ebola virus, the head of the World Health Organization said Sunday during a visit to Bunia in eastern Congo.
Community unites for Fenway Health’s Strides for Action 5K in Boston
Hundreds of advocates and community leaders came together Sunday morning to support HIV prevention and treatment, LGBTQIA+ health services, research, and advocacy.
Why Trump reversed course to fast-track psychedelic drugs for mental healthcare
President Donald Trump is trying to fast-track research into psychedelics as treatments, creating new opportunities and risks.
WHO chief hails 5 Ebola recoveries as a new treatment center opens in eastern Congo
The World Health Organization reports that five patients have recovered from a rare type of Ebola in eastern Congo.
WHO chief hails 5 Ebola recoveries as a new treatment center opens in eastern Congo
The World Health Organization reports that five patients have recovered from a rare type of Ebola in eastern Congo.
Local Business Spotlight: Loon Lake Lodge
When guests arrive at Loon Lake Lodge, they are welcomed by Andrea and Derek Hofeldt and their three boys into an atmosphere filled with outdoor adventure, family connection, and relaxation along the Gunflint Trail. From donut fishing and watermelon-eating contests to hydro bikes and quiet time by the lake, the Hofeldt family—who own and operate...
How Nigeria’s ‘algorithmic apothecary’ fuels a surge in risky herbal cures
Unverified herbal remedies promoted on social media are driving rising health risks and delayed treatment in Nigeria.
Opinion: In a tense political atmosphere, the Bishop-Schuerch campaign is a breath of fresh air
Alaska voters have a chance to reward candidates who can work beyond party lines.
Infinity Ward Vows Modern Warfare 4 Stays Grounded, Slams Door on Lady Gaga, Nicki Minaj and Omni-Man Skins
Infinity Ward dumped a lot of information on Call of Duty: Modern Warfare 4 all at once on Thursday, May 28. Among the reveals, the studio also shared that cosmetics and collaborations won't betray the game's grounded atmosphere, unlike in other recent installments. On the studio's X account, they tweeted: Every aspect of Modern Warfare 4 is anchored in the game's narrative. Every feature, every decision needs to feel authentic to what Modern Warfare is, and that includes cosmetics and collabs. We're committed to keeping it grounded and transparent, and we want to hear from you on what you'd like […]
Governor Gianforte Announces Montana Secures Federal Funding to Establish Behavioral Health Clinics
HELENA, Mont. – Governor Greg Gianforte and Department of Public Health and Human Services (DPHHS) Director Charlie Brereton today announced the Trump administration selected Montana as one of ten states to receive federal funding to expand access to mental health and substance use disorder treatment across the state.
HHS Unveils Sweeping Plan to Combat Lyme Disease and Advance Treatment
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. today announced a series of major initiatives to strengthen the nation’s response to Lyme disease and other tick-borne illnesses.
3 receiving preventive treatment after exposure to rabid bat in Snohomish County home
Three Snohomish County residents are receiving preventive treatment for rabies after being exposed to a bat that tested positive for the virus, county health of
What to know about the Bundibugyo virus, form of Ebola causing an outbreak in Congo
The virus causing an outbreak in Congo suspected of killing more than 200 people is less common than others that cause Ebola disease, which is complicating the response because there are no specific treatments or vaccines.
Astronomers finally solve Saturn’s decades-long spin mystery
A decades-old mystery about Saturn has finally been solved thanks to the James Webb Space Telescope. Scientists discovered that Saturn’s changing “rotation rate” was never caused by the planet speeding up or slowing down, but by powerful winds high in its atmosphere. Webb’s unprecedented observations revealed that Saturn’s northern lights actively heat the atmosphere, creating winds that generate electrical currents, which then power the aurora all over again in a self-sustaining cycle.
Reducing the Stigma Around Mental Health
We have to engage with skeptics if we want people to accept that mental health conditions require medical treatment.
Everton quickfire end of season review
Everton's season feels like a mixed bag in all honesty and I was tempted to go with the 3-0 home win over Chelsea, as it was an emphatic performance and a real moment that Hill Dickinson Stadium felt like it was encapsulating the Goodison atmosphere. Trailing 1-0 at the break, James Garner was then booked quickly followed by a yellow for David Moyes. It started a feisty reaction much like those at Goodison Park when fans felt a sense of injustice.
The woman behind the world’s biggest longevity competition
Jamie Justice of XPRIZE Healthspan on the most promising research and "purely scammy" treatments in the world of longevity.
Bone Health During Breast Cancer
Some breast cancer treatments lower estrogen and can weaken bones. Find out why and how to keep your bones strong during treatment and beyond.
Chris Evert says Jannik Sinner 'shouldn't have been allowed' to leave court during French Open controversy
Chris Evert draws the line on star treatment in tennis, saying Sinner's French Open medical timeout violated clear rules on cramping timeouts.
Americans who get Ebola will go to Europe for treatment, not U.S., officials say
Trump administration officials said the CDC and State Department are working to figure out where those treatment facilities could be.
HIV, Brain Health Research, and How It Could Benefit Everyone
Brain health research in people living with HIV could improve existing treatments and facilitate discovery of new interventions for other diseases.
New study shows atmospheric compounds formed from tire wear may pose human health risk
Tire rubber contains antioxidant chemicals, most notably 6PPD and DPPD, that are released into the air as tiny particles during normal driving. A single compound formed from 6PPD, known as 6PPD-quinone ...
Polish scientists and students rally in campaign for 3% funding target
Polish scientists and students have been flooding social media with calls on the government to raise research and development spending as part of 3% for Science, 100% for Poland, a campaign born earlier this month out of frustration with chronic underfunding in the academic sector. On May 27, thousands took the slogan on to the streets.The EU has been trying to convince member states to raise their R&D expenditures to 3% of GDP for more than two decades, but the idea has never gained traction in capitals. Finance ministers were too busy plugging budget holes created in the aftermath of the 2008 crisis, then the Covid pandemic, the war in Ukraine, and now the war in Iran.Critics say that countries missed or ignored the target because it is voluntary, but also because research communities have rarely raised their voice to put pressure on national governments. The European Commission hopes to make the target legally binding in the upcoming European Research Area Act, an EU-wide regulation that should be announced by the end of the year. Academia in Poland has been faced with a funding crisis for years, often leaving its members with no other choice but to work abroad in order to access better resources, or leave the sector altogether in the hope of earning a decent living. The risk, in the long-term, is that brain drain stifles local innovation capacity and technological competitiveness.In just a few weeks, the movement rallied nationwide support, including from major academic bodies and trade unions such as the Conference of Rectors of Academic Schools in Poland and the Presidium of the Polish Academy of Sciences. Its public petition collected more than 23,000 signatures. On May 27, it formed the first large protest for science in Poland, gathering thousands of people in front of the parliament building in Warsaw.Ilona Uryga-Bugajska, representative of the Marie Curie Alumni Association Poland Chapter, was there. “The protest was peaceful, with no incidents reported, and the entire event took place in a respectful and calm atmosphere,” she said. Banners she saw in the crowd carried slogans such as “A little longer and I’ll be teaching in a supermarket,” “National culture, starvation salary,” “Stop the destruction of science,” “Passion will not pay the rent,” “Without action, don’t expect a better future,” and “Pull science out of the hole.” She also observed a strong presence of young researchers, who are on the frontline of Poland’s academic crisis.“Academics are usually people who prefer discussion, analysis, dialogue and compromise. We are not a group that protests easily,” said Katarzyna Marzec, professor at the Faculty of Pharmacy of the Jagiellonian University Medical College and AGH University of Krakow, who also took part. “But many of us feel that we have been pushed against the wall.”Aleksandra Rutkowska, translational neuroscientist and research group leader at the Medical University of Gdańsk, agreed. “Frustration in the scientific community is very high,” she said. “Science is often used politically as a symbol of innovation and modernity, but the everyday reality inside many institutions is much more difficult. There is a large gap between the public narrative and the actual condition of the sector.”Maria Wiktoria Górna, head of the structural biology group at the University of Warsaw and one of the organisers of the movement, told Science|Business that the campaign would continue without proven results. This might involve another strike in the autumn, she said. “Empty promises are not enough by now.”Campaign demandsAccording to Uryga-Bugajska, the organisers officially presented their demands and concerns to representatives of the government present at the event. These included Marek Gzik, deputy minister of science and higher education, and Karolina Zioło-Pużuk, secretary of state of that same ministry.The headline demand, for the government to increase national spending on R&D to 3% of GDP by 2030, should be within Poland’s economic capacity, Rutkowska said. “The real question is whether there is genuine long-term political commitment to treating science as a strategic priority rather than a slogan.”In 2024, R&D expenditure in Poland stood at 1.41% of GDP, which is slightly above the average for central and eastern Europe, with countries such as Czechia recording 1.82%, Hungary 1.31% and Romania 0.46%. However, it falls noticeably short of the EU average of 2.24%, which just a handful of countries exceed, including Germany, Belgium and Sweden.Campaigners are also asking for fair wages for scientific staff, including PhD stipends and junior academic salaries, which are widely considered uncompetitive. Starting doctoral scholarships amount to some €843 gross per month, when the statutory minimum wage stands at €1,135. By pushing early-career researchers out of Poland, growing precarity has caused a generational gap in the academic workforce, with just 25% of lecturers aged under 40. In this context, the movement fears that scientific careers could soon be accessible to a privileged minority only.Grzegorz Spólnik is a case in point. After 15 years working in mass spectrometry at the Polish Academy of Sciences, he decided to leave partly “to earn enough money to live a normal life,” he said. “At that time, my earnings were similar to those of people working in grocery shops, and the work-life balance is something that does not exist in science, or is very hard to achieve.”Now a senior field service engineer for Polish laboratory equipment supplier Bioanalytic, he would consider going back to research, “but never in the public sector, maybe some start-up or a big private company with ambitious R&D.”The campaigners want to see more support for basic research and have called for €236 million to be added to the budget of the National Science Centre (NCN) in 2027 so that the average grant application success rate does not fall below 25%.“At the protest, there was a banner I particularly liked: ‘NCN is not a lottery.’ Unfortunately, for many researchers, it increasingly feels exactly like one,” Marzec said. “Personally, I am one of the lucky ones. I work at two of the strongest institutions in the country, where the research standards are very high. I know that in many other institutions, the situation is much worse and obtaining funding for research at an early-career stage is becoming nearly impossible.”Rutkowska also considers herself fortunate. After studying abroad and holding a postdoctoral position, she returned to Poland, where her pay was supported through an NCN-funded project linked to the Marie Skłodowska-Curie Actions. “This also made me very aware that good research conditions in Poland often depend on external competitive funding rather than on stable support from the system itself,” she said.Long-term strategyBeyond the lack of funds for both salaries and grants, scientists believe that the issue is structural. “The biggest problem at the moment is the complete lack of a clear long-term strategy for the development of science and research from the current government,” Marzec said. “Everything ends with declarations and promises that are never truly followed by concrete actions or structural reforms.”Rutkowska agreed, citing a lack of infrastructure, continuity and long-term institutional support.“Running a research group in Poland often means functioning as an entire institution at once,” she said. “I am a principal investigator, a mentor, a recruiter, a project administrator and, when needed, still someone who returns to the lab bench to help with experiments,” she went on. “This creates a large hidden workload that takes time and energy away from actual science. At times, it feels as though scientists are no longer expecting extra help; we simply hope the system will stop creating additional obstacles that make research unnecessarily difficult.”Related articlesStrategic thinking: Germany funds joint research with Poland and FrancePoland to transfer €30M of regional funds to boost Horizon Europe participationPoland is funding fewer basic research grants as high inflation hitsIn short, “academics are expected to teach, publish papers, apply for grants and conduct high-quality research, while funding and salaries remain very limited,” said Uryga-Bugajska, who returned to her home country after 13 years in the UK.According to Marzec, another issue is the way that research institutions are evaluated. Previously, this took place every four years, with a clear differentiation between stronger and weaker institutions. “The current government, perhaps to avoid political backlash, effectively concluded that everyone is doing well, so in practice no meaningful evaluation took place,” she said.But in her view, “some form of serious assessment is necessary” to ensure the excellence and international competitiveness of Polish institutions, and to determine how to best use public resources and where institutional structures need reform. “Some institutions may need to rethink hiring practices in order to attract ambitious young researchers who are capable of obtaining competitive grants and building internationally visible research groups.” Rutkowska has already had to adapt. “When hiring PhD students, I often have to combine different funding sources creatively to make positions attractive enough for talented people to stay in science,” she said. “Many young researchers do not see a stable future in academia in Poland, and that is deeply worrying.”
Forget LASIK: Safer, cheaper vision correction without lasers or surgery
Researchers are developing a futuristic alternative to LASIK that reshapes the eye without lasers or incisions. Using mild electrical pulses and platinum contact lenses, they temporarily soften the cornea so it can be molded into a new shape. Early tests on rabbit eyes successfully corrected nearsightedness in about a minute while preserving the eye’s structure.
Polish scientists and students rally in campaign for better conditions
Polish scientists and students have been flooding social media with calls on the government to raise research and development spending as part of 3% for Science, 100% for Poland, a campaign born earlier this month out of frustration with chronic underfunding in the academic sector. On May 27, thousands took the slogan on to the streets.The EU has been trying to convince member states to raise their R&D expenditures to 3% of GDP for more than two decades, but the idea has never gained traction in capitals. Finance ministers were too busy plugging budget holes created in the aftermath of the 2008 crisis, then the Covid pandemic, the war in Ukraine, and now the war in Iran.Critics say that countries missed or ignored the target because it is voluntary, but also because research communities have rarely raised their voice to put pressure on national governments. The European Commission hopes to make the target legally binding in the upcoming European Research Area Act, an EU-wide regulation that should be announced by the end of the year. Academia in Poland has been faced with a funding crisis for years, often leaving its members with no other choice but to work abroad in order to access better resources, or leave the sector altogether in the hope of earning a decent living. The risk, in the long-term, is that brain drain stifles local innovation capacity and technological competitiveness.In just a few weeks, the movement rallied nationwide support, including from major academic bodies and trade unions such as the Conference of Rectors of Academic Schools in Poland and the Presidium of the Polish Academy of Sciences. Its public petition collected more than 23,000 signatures. On May 27, it formed the first large protest for science in Poland, gathering thousands of people in front of the parliament building in Warsaw.Ilona Uryga-Bugajska, representative of the Marie Curie Alumni Association Poland Chapter, was there. “The protest was peaceful, with no incidents reported, and the entire event took place in a respectful and calm atmosphere,” she said. Banners she saw in the crowd carried slogans such as “A little longer and I’ll be teaching in a supermarket,” “National culture, starvation salary,” “Stop the destruction of science,” “Passion will not pay the rent,” “Without action, don’t expect a better future,” and “Pull science out of the hole.” She also observed a strong presence of young researchers, who are on the frontline of Poland’s academic crisis.“Academics are usually people who prefer discussion, analysis, dialogue and compromise. We are not a group that protests easily,” said Katarzyna Marzec, professor at the Faculty of Pharmacy of the Jagiellonian University Medical College and AGH University of Krakow, who also took part. “But many of us feel that we have been pushed against the wall.”Aleksandra Rutkowska, translational neuroscientist and research group leader at the Medical University of Gdańsk, agreed. “Frustration in the scientific community is very high,” she said. “Science is often used politically as a symbol of innovation and modernity, but the everyday reality inside many institutions is much more difficult. There is a large gap between the public narrative and the actual condition of the sector.”Maria Wiktoria Górna, head of the structural biology group at the University of Warsaw and one of the organisers of the movement, told Science|Business that the campaign would continue without proven results. This might involve another strike in the autumn, she said. “Empty promises are not enough by now.”Campaign demandsAccording to Uryga-Bugajska, the organisers officially presented their demands and concerns to representatives of the government present at the event. These included Marek Gzik, deputy minister of science and higher education, and Karolina Zioło-Pużuk, secretary of state of that same ministry.The headline demand, for the government to increase national spending on R&D to 3% of GDP by 2030, should be within Poland’s economic capacity, Rutkowska said. “The real question is whether there is genuine long-term political commitment to treating science as a strategic priority rather than a slogan.”In 2024, R&D expenditure in Poland stood at 1.41% of GDP, which is slightly above the average for central and eastern Europe, with countries such as Czechia recording 1.82%, Hungary 1.31% and Romania 0.46%. However, it falls noticeably short of the EU average of 2.24%, which just a handful of countries exceed, including Germany, Belgium and Sweden.Campaigners are also asking for fair wages for scientific staff, including PhD stipends and junior academic salaries, which are widely considered uncompetitive. Starting doctoral scholarships amount to some €843 gross per month, when the statutory minimum wage stands at €1,135. By pushing early-career researchers out of Poland, growing precarity has caused a generational gap in the academic workforce, with just 25% of lecturers aged under 40. In this context, the movement fears that scientific careers could soon be accessible to a privileged minority only.Grzegorz Spólnik is a case in point. After 15 years working in mass spectrometry at the Polish Academy of Sciences, he decided to leave partly “to earn enough money to live a normal life,” he said. “At that time, my earnings were similar to those of people working in grocery shops, and the work-life balance is something that does not exist in science, or is very hard to achieve.”Now a senior field service engineer for Polish laboratory equipment supplier Bioanalytic, he would consider going back to research, “but never in the public sector, maybe some start-up or a big private company with ambitious R&D.”The campaigners want to see more support for basic research and have called for €236 million to be added to the budget of the National Science Centre (NCN) in 2027 so that the average grant application success rate does not fall below 25%.“At the protest, there was a banner I particularly liked: ‘NCN is not a lottery.’ Unfortunately, for many researchers, it increasingly feels exactly like one,” Marzec said. “Personally, I am one of the lucky ones. I work at two of the strongest institutions in the country, where the research standards are very high. I know that in many other institutions, the situation is much worse and obtaining funding for research at an early-career stage is becoming nearly impossible.”Rutkowska also considers herself fortunate. After studying abroad and holding a postdoctoral position, she returned to Poland, where her pay was supported through an NCN-funded project linked to the Marie Skłodowska-Curie Actions. “This also made me very aware that good research conditions in Poland often depend on external competitive funding rather than on stable support from the system itself,” she said.Long-term strategyBeyond the lack of funds for both salaries and grants, scientists believe that the issue is structural. “The biggest problem at the moment is the complete lack of a clear long-term strategy for the development of science and research from the current government,” Marzec said. “Everything ends with declarations and promises that are never truly followed by concrete actions or structural reforms.”Rutkowska agreed, citing a lack of infrastructure, continuity and long-term institutional support.“Running a research group in Poland often means functioning as an entire institution at once,” she said. “I am a principal investigator, a mentor, a recruiter, a project administrator and, when needed, still someone who returns to the lab bench to help with experiments,” she went on. “This creates a large hidden workload that takes time and energy away from actual science. At times, it feels as though scientists are no longer expecting extra help; we simply hope the system will stop creating additional obstacles that make research unnecessarily difficult.”Related articlesStrategic thinking: Germany funds joint research with Poland and FrancePoland to transfer €30M of regional funds to boost Horizon Europe participationPoland is funding fewer basic research grants as high inflation hitsIn short, “academics are expected to teach, publish papers, apply for grants and conduct high-quality research, while funding and salaries remain very limited,” said Uryga-Bugajska, who returned to her home country after 13 years in the UK.According to Marzec, another issue is the way that research institutions are evaluated. Previously, this took place every four years, with a clear differentiation between stronger and weaker institutions. “The current government, perhaps to avoid political backlash, effectively concluded that everyone is doing well, so in practice no meaningful evaluation took place,” she said.But in her view, “some form of serious assessment is necessary” to ensure the excellence and international competitiveness of Polish institutions, and to determine how to best use public resources and where institutional structures need reform. “Some institutions may need to rethink hiring practices in order to attract ambitious young researchers who are capable of obtaining competitive grants and building internationally visible research groups.” Rutkowska has already had to adapt. “When hiring PhD students, I often have to combine different funding sources creatively to make positions attractive enough for talented people to stay in science,” she said. “Many young researchers do not see a stable future in academia in Poland, and that is deeply worrying.”
Medicaid’s Vital Role in Mental Health and Substance Use Disorder Care
Mental Health Awareness Month is an opportunity to recognize Medicaid’s essential role in helping people access mental health care and treatment for substance use disorder. As the nation’s largest payer for mental health and substance use disorder care, Medicaid covers approximately twenty two million non-elderly Americans with these conditions who rely on the program’s essential […]
HEALTH FIRST: Technology advancements in cancer treatment
Advancements in cancer treatment are giving patients new options.
New depression treatment targets the immune system instead of the brain
A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system. In a small clinical trial, researchers found that an anti-inflammatory drug normally used for rheumatoid arthritis appeared to ease symptoms in people with hard-to-treat depression, while also reducing fatigue and anxiety and improving quality of life.
In Good Health: Chronic Pelvic Pain In Women
Chronic pelvic and vulvovaginal pain is surprisingly common among women of all ages. In fact, 1 in 3 women will experience a pelvic floor disorder at some point in their lifetimes.So, why is it so difficult to receive diagnosis and treatment for these conditions? And why don’t we talk about our pain ‘down there’ in general?In this installment in our series, “In Good Health,” we sit down with a panel of experts to talk about it.Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.
Scotland Health’s home-based care program earns AHA Rural Hospital Excellence in Innovation Award recognition
Scotland Health at Home began with one goal: Connect patients to treatment, no matter where they were.
Mini world near Pluto is far more active than it should be – and experts are baffled | BBC Science Focus Magazine
A miniature world beyond Neptune appears to have an atmosphere, despite being too small to hold onto one
Dragon Quest XI Gets The 'Definitive Edition' Treatment (Again) For Switch 2
Dive back in this September
Ebola, chemical plants and health, hantavirus, common colds, heat and more
As they say, bugs have ears. Public health has had a relentless May. Chemical plant (near) explosions, Ebola, hantavirus, and that's before you even get to the usual suspects: common colds, heat, and ticks. Here’s an attempt to keep you up to speed and, more importantly, what it means for you and your community. But first, an announcement: World Cup The World Cup starts in 15 days (not like anyone is counting down), and we are hanging TVs in the Health Security Operations Center. It’s going to be a gorgeous, chaotic celebration of basically every culture on earth. And it’s going to take a team effort—from communities to individuals, from public health to health care—to keep people healthy. That’s where you come in. If you’re going to the games or live within 30 miles of a stadium, we would love to hear from you. Sign up for a weekly survey here. Thanks to the more than 1,280 people who have already signed up…you will be hearing from us soon!! Global disease “weather report” Hantavirus: Two more cases The global count of cruise ship passengers with hantavirus has now increased to 13 cases (11 confirmed), with three deaths. The two new cases are overseas and among people who were already quarantining: A crew member in the Netherlands. A Spanish national passenger who was quarantining at home tested positive through daily monitoring. They are now in a biocontainment unit. In the U.S., everyone remains negative. There may be more cases, given that the incubation period of hantavirus (the time from exposure to infection) is 45 days. But this week, we will reach a major milestone: the median incubation window is 18 days, and that will pass on May 29. What this means for you: Your risk from this cruise ship outbreak remains essentially nil at this point. Ebola rages on in Central Africa Big thanks to Dr. Craig Spencer, a humanitarian physician who has treated and survived Ebola, for jumping in to provide the YLE community with an update. Craig, take it from here… The combined confirmed and suspected Ebola cases in DRC are now more than 1,000. All signs are pointing to a very long and catastrophic outbreak in Central Africa: This is a vast undercount. We know this because the test positivity rate is hovering around 50%, only 20% of contacts are being traced (and in some areas, no contacts at all), and more cases keep popping up with no known connection. This all points to widespread and undetected community transmission. This is in only a week of detection. Compared to previous outbreaks, the growth is very fast, as the huge West Africa outbreak in 2016 was first detected at 49 cases and rose to 208 cases a month later. It took four months for that outbreak to reach the size of the current one in the DR Congo. The cases are spread out across 16 health zones. There are now multiple epicenters, making containment very difficult. Next door in Uganda, the case count is seven. While this number is low compared to DRC, a concerning development is that two health care workers recently tested positive with uncertain exposure histories. If they weren’t treating known Ebola cases, this means it’s spreading undetected in Uganda as well. On the ground, backlash, including the burning of health centers, has emerged, a pattern seen in nearly every outbreak and rooted in deep community distrust. It often stems from outside actors working in communities without fully understanding or addressing local priorities. Affected populations may recognize the severity of Ebola while still holding other concerns as more pressing, such as where their loved ones are buried. Community trust is essential to an effective response, but difficult to build during an active emergency. It is best established long before a crisis begins. U.S. priorities are made clear, and may backfire. The U.S. Administration has shown that its first priority is keeping Ebola out, with helping end the outbreak in the DRC a secondary concern. That's meant travel restrictions broader than anything we've imposed before — covering travelers from across the region, and reportedly some green card holders and permanent residents as well. For example, just these past two days, news broke that high-risk American travelers will be subject to a mandatory quarantine in Kenya before they are allowed to return. If an American is infected, the U.S. government plans to send them to a hospital it is standing up from scratch in Kenya. (Currently, Americans who were in the area are allowed to return but are diverted to three airports—Houston, Atlanta, and DC—for further screening.) Past administrations have used travel notices and stepped-up screening; this goes much further. At first blush, these strict precautions may sound prudent. But this approach could backfire in three ways: Restrictions this blunt give people every reason to hide where they’ve been and whom they’ve been near — making the people we most need to find harder to track, not easier. They also breed a false sense that this is someone else’s problem. But diseases are humbling. They find the small cracks in even the most impenetrable-seeming defenses. Lives lost. There is no treatment for this Ebola strain, which means survival depends heavily on the quality of the health system. We have that system in the States, but we are choosing not to use it for infected Americans. This is unbelievable and infuriating. (See a deeper dive from me here.) The only real way to lower the risk to Americans — and everyone else — is to end the outbreak in the DRC and across the region. What this means for you: If you have travel plans to this region, it’s time to cancel them. This is a high-risk situation in Central Africa, and CDC released a Level 4 Travel Advisory. There is also great uncertainty if and when the Administration will let you back in. To the general public in the U.S., your risk remains very, very low right now. U.S. disease “weather report” Ticks: past peak season? Good news, especially for people in the Northeast and Midwest: tick numbers continue to decline. Though we are at the peak of the season, this unusually early year is trending favorably. Heat-related illnesses in the North Heat risk is certainly not blanketing the entire country yet, but this week it will be moderate in the Midwest and the Southeast. What this means for you: Be sure to check the CDC HeatRisk tool. A red day isn’t the best day for that soccer game for a kid with asthma, and a stretch of orange days is a great time to check on your elderly neighbor. Common colds surging As far as respiratory viruses go, the only thing really going around right now is the common cold. It is higher this year than last year, but should peak very soon before returning this fall. Spotlight: Chemical plants Over the weekend, YLE California covered the serious situation that unfolded around a chemical plant in Orange County, California. Thankfully, the worst-case scenario (a chemical explosion) was mitigated, but only through luck. The health implications in a densely populated area could have been catastrophic. As the situation was winding down, another chemical explosion struck Washington State. This one was fatal. Health officials say the risk to surrounding residents from chemicals in the air and ground remains low, though the community deserves far greater clarity. Clean air and clean water consistently rank as Americans’ top public health concerns — yet when chemical disasters strike, communities are too often met with reassurances rather than transparency and accountability. Residents near the 2023 East Palestine, Ohio train derailment, for example, are still waiting to understand the long-term impact on their health, with few clear answers. What this means for you: Many are wondering if facilities processing potentially dangerous materials are in their neighborhoods. This interactive map allows you to enter your ZIP code and see all facilities monitored by the EPA, including any violations. Good news Ebola vaccines and treatment for the Bundibugyo species are in development. Two vaccine platforms are being explored, at least one of which may be deployable in as little as 2 months. One vaccine is being developed by Oxford, and the other uses the same biotechnology as the FDA-approved Zaire species of Ebola. (It may provide cross-protection, but it’s unclear at this point.) On the treatment side, two promising monoclonal antibody cocktails are likely to be deployed, though doses are limited and logistical hurdles remain significant challenges. Anni over at The Biotech Tea had a great explainer about the Ebola vaccine gap, if you want to read more. [ The Biotech Tea The Ebola vaccine gap, reading vessel damage, & the Makary exit 🗝️ Paid subscribers get the Biotech Term of the Week at $30/year (~$2.50/month). I try to keep it intentionally accessible, but if cost is ever a barrier, send me a message. A few people asked about expensing your subscription, so I put together a short email template… Read more 6 days ago · 10 likes · Annicka Evans, PhD ](https://www.thebiotechtea.com/p/the-ebola-vaccine-gap-reading-vessel?utm_source=substack&utm_campaign=post_embed&utm_medium=web) Polycystic ovary syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS), following more than a decade of debate and input from roughly 22,000 clinicians, researchers, and patients worldwide. This is good because the old name was medically misleading, leading to patients without visible cysts being dismissed or overlooked entirely. The WHO estimates that 70% of people with the condition remain undiagnosed. A more accurate name should improve recognition, reduce stigma, and ultimately help the millions of people living with this condition get diagnosed and treated sooner. Poll Loading... Bottom line Public health situations are everywhere right now. Staying healthy takes public health professionals and systems working tirelessly behind the scenes and each of us showing up for our neighbors and communities. Love, YLE Big thanks to Ed Nirenberg for staying on top of the Ebola vaccines, Hannah Totte for all the figures, Dr. Craig Spencer for the Ebola insight, and Dr. Matt Willis for covering the chemical situation in CA. Your Local Epidemiologist (YLE) comprises a team of experts, ranging from physicians to immunologists to epidemiologists to nutritionists, working together with one goal: to “Translate” ever-evolving public health science so that people are well-equipped to make evidence-based decisions. YLE suite of newsletters reaches over 475,000 people across more than 132 countries. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
WATCH: Asian-owned business celebrates 50 years in Tempe
Little Szechuan started out as the Szechuan Inn in 1976. Five decades later, its food, small business atmosphere and owners still bring the community together.
Zlatan Ibrahimović and Tom Brady Compare American Sports Atmospheres To European Soccer
Zlatan Ibrahimovic and Tom Brady compare sports atmospheres
Banner Health report shows Arizona research driving national medical innovation
Milestones in Research details 1,300 clinical and translational research studies, FDA-approved heart device, landmark Alzheimer's prevention work Dr Wilber Su Wilber Su, MD, cardiologist for Banner Health, in the operating room. Phoenix, May 26, 2026 (GLOBE NEWSWIRE) -- Banner Health's $80.5 million research enterprise delivered breakthrough treatments to Arizona patients in 2025 while advancing wide-ranging therapies toward FDA approval, according to the organization's annual Milestones in Rese
007 First Light GeForce Game Ready Driver Released
Download and install to optimize your experience in the latest releases featuring DLSS and RTX technologies, including 007 First Light, LEGO® Batman™: Legacy of the Dark Knight, EA SPORTS™ F1® 25: 2026 Season Pack, and World of Tanks: HEAT.
Why is hantavirus so deadly? It’s not what you may think
Andes hantavirus causes deadly lung failure, but its method of attack differs from other respiratory illnesses. The details might inform future treatments.
Scientists say they’ve reversed brain aging with a simple nasal spray
Researchers at Texas A&M have developed a nasal spray that appears to reverse brain aging by calming inflammation and restoring the brain’s energy systems. After just two doses, memory and cognitive function improved for months, raising hopes for future treatments targeting dementia and brain fog.
‘The patient is a VIP’: Inside Jeffrey Epstein’s close ties to Mount Sinai Hospital
Epstein’s special treatment from the hospital included doctors being at his beck-and-call, including for house calls, and giving preferential treatment to his friends for medical care and job prospects.
DRC is no stranger to Ebola outbreaks. Why isn’t there a vaccine or treatment to help now?
The fast-growing Ebola outbreak in the Democratic Republic of Congo came to the world’s attention only a little more than a week ago and is already the third-largest on record. But it’s the 17th outbreak the country has dealt with since the virus was discovered there in 1976.
Leo International Precision Health AG builds a Synchronised, End-to-End Precision Healthcare Engine Across the Entire Patient Journey
LIPH AG introduces a synchronised “Precision Health Engine” designed to transform healthcare from reactive treatment into predictive, personalised and continuous care. Planegg / Martinsried, Germany, May 26, 2026 – Leo International Precision Health AG (“LIPH AG” or the “Company”, ticker symbol: LEOW), a holding company building a global AI-driven healthcare ecosystem and listed on the Frankfurt Stock Exchange, continues to expand its precision health platform integrating Healthcare Services, Me
NASA’s Psyche spacecraft uses Mars as a giant slingshot toward a mysterious metal world
NASA’s Psyche spacecraft just used Mars as a giant gravitational slingshot to continue its journey toward a strange metal rich asteroid. The close flyby boosted the spacecraft’s speed by about 1,000 mph while also producing rare crescent images of Mars glowing through its dusty atmosphere.
Sennheiser's Momentum 5 headphones are all about the audio and ANC upgrades
Sennheiser's latest Momentum headphones offer key audio and ANC improvements, including Dolby Atmos with head tracking.
African Health Officials On Ebola: ‘This Is Too Much’ (Live Updates)
Several treatment centers have been destroyed and tensions are rising in Congo, the center of the Ebola outbreak.
Thieves smash into South Side business, steal from ATM, Chicago police say
Thieves used two vehicles to smash into a South Side business and steal from an ATM Monday morning, Chicago police said.
Common heart drug taken by millions found useless
A massive international study could upend 40 years of heart attack treatment. Researchers found that beta blockers—routinely prescribed after uncomplicated heart attacks—offered no real benefit for patients whose heart function remained normal, despite being given to millions worldwide. Even more surprising, women taking the drugs faced a higher risk of death, repeat heart attack, or hospitalization for heart failure compared to women who didn’t receive them.
Attacks on Ebola treatment centers are one of several problems affecting Congo's outbreak response
Experts say several crises combine to make the Ebola outbreak in eastern Congo difficult to contain.
Attacks on Ebola treatment centers are one of several problems affecting Congo's outbreak response
Experts say several crises combine to make the Ebola outbreak in eastern Congo difficult to contain.
Attacks on Ebola treatment centers are one of several problems affecting Congo's outbreak response
Experts say several crises combine to make the Ebola outbreak in eastern Congo difficult to contain.
Political Division Is Damaging Therapeutic Alliances
Opposing views between patients and therapists related to the Palestinian-Israeli conflict have led to ruptured treatment. It is the patients who are harmed.
Scientists say house cats could help unlock new cancer treatments for humans
Scientists have cracked open the “black box” of feline cancer in a landmark study that genetically analyzed nearly 500 cat tumors from around the world. The research uncovered striking similarities between cancers in cats, dogs, and humans — including shared cancer-driving genes tied to aggressive breast cancers.
Second Ebola treatment center set on fire in epicenter of disease's outbreak
A second Ebola treatment center is set ablaze in eastern DR Congo, with 18 suspected cases fleeing
Angry residents of a town at the epicenter of the Ebola outbreak in eastern Democratic Republic of Congo (DRC) attacked and burned a tent that was part of a health center where people are being treated for the virus, the staff there said Saturday. It was the second such attack in the region in a week.
Eighteen suspected Ebola patients escape after treatment tent is set on fire for a second time in Congo
A tent used for treatment of the Ebola outbreak in eastern Congo was set on fire for the second time this week, and 18 people suspected of infection escaped, a local hospital director said Saturday.
5 Takeaways From a Times Investigation on Autism Therapy Clinics
A rapidly growing industry often overprescribes treatment to young children with autism, who spend as many as 40 hours a week at the facilities.
People with eating disorders are taking GLP-1s and doctors are alarmed
Providers said they are encountering patients seeking treatment for anorexia, bulimia and binge eating disorder who are taking GLP-1 drugs.
BATMAN to the rescue: TMVR technique helps cardiologists reduce risk of LVOT obstruction
LVOT obstruction is a serious complication of TMVR. BATMAN may help protect patients from LVOT obstruction without leading to any additional risks.
LEGO Batman Comparison Shows Difference Between Xbox Series X And Series S
How the Xbox versions stack up
Ebola outbreak live updates: WHO upgrades risk to 'very high' and warns virus 'spreading rapidly'
Meanwhile, an American doctor who was flown to Germany for treatment after contracting the virus in the Democratic Republic of Congo is "critically ill," his missionary group says.
Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification
Anavex Life Sciences Corp. (“Anavex” or the “Company”)(Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous system (CNS) disorders, today announced it received anexpected delinquency notification letter (the “Notice”) from the Listing QualificationsDepartment of The Nasdaq Stock Market LLC (“Nasdaq”) on May 20, 2026.
World Health Assembly endorses resolution on precision medicine
At the Seventy-ninth World Health Assembly, Member States endorsed a new resolution on Precision medicine: a path towards targeted, personalized and equitable care, taking an important step towards advancing precision medicine as part of efforts to strengthen equitable, effective and sustainable health systems. Precision medicine refers to the use of clinical, molecular, genomic and other health data to inform prevention, diagnosis and treatment, taking into account variability while applying appropriate ethical and legal safeguards. When integrated responsibly into health systems, precision approaches can improve outcomes across different disease areas and across the life course – from cancer and rare diseases to infectious diseases, maternal, newborn and child health, mental health and noncommunicable diseases. The resolution reflects rapid advances in genomics, diagnostics, data science and digital health, alongside widening global inequities in access to these innovations. Many populations – particularly in low- and middle-income countries – remain underrepresented in data and research, limiting the public health impact of precision medicine and risking the widening of health disparities if action is not taken now. "Precision medicine is not an aspirational idea for health delivery in the future – it is already transforming lives across the world. But its benefits remain out of reach for too many and the research driving progress is concentrated in high income countries. This WHA resolution gives global health leaders, ministries of health, and WHO a clear mandate: to act. From infant screening to setting up genomic databases WHO will work with countries to bring about the power of these innovations." Dr Meg Doherty, Director Science for HealthThrough the resolution, Member States commit to developing and strengthening national policies, infrastructure, workforce capacity and governance frameworks to support the safe, ethical and equitable integration of precision medicine into health systems, aligned with universal health coverage. This includes promoting affordability, ensuring inclusive research and data systems, strengthening regulation and data governance, and fostering collaboration across sectors and regions.WHO is requested to provide technical and normative support, review and coordinate existing guidance, facilitate global and regional collaboration, and develop a Global Strategy on Precision Medicine to guide equitable and context‑appropriate implementation. WHO stands ready to support Member States through tools such as a country maturity model for countries to self-assess capacity in implementing precision medicine depending on their context. In the immediate term WHO will map all existing guidance and frameworks and host extensive consultations with interest holders globally.By placing equity, inclusion and public value at the centre of precision medicine, the resolution reinforces WHO’s commitment to ensuring that scientific advances benefit all people, everywhere, and that no one is left behind in the next era of health innovation."By uniting people-centered healthcare with innovation, precision medicine has the potential to transform lives. This resolution helps ensure those advances serve the shared goal of health for all." Dr Sylvie Briand, Chief Scientist For further information please visit the Health Topic: Genomics
Ebola treatment center in Congo set on fire as fear and anger over disease's spread grow
People set fire to an Ebola treatment center in a town at the heart of the outbreak in eastern Congo as fear and anger grow over a health crisis that doctors are struggling to contain.
3 Medical Routines That Older People May Not Need
Some screenings and treatments no longer make sense for patients as they age. Researchers have just added a few more to the list.
New Orleans hospital offers new radiotherapy that tracks tumors during treatment: 'More precise, more personal'
"Less recurrence. More cure. Less side effects. Better patient experience," said Dr. Christophe Marques, a radiation oncologist with Ochsner Health.
Something coming: what scientists know about a potential 'super' El Nino
Forecasters say a potentially "super" El Niño is rapidly taking shape in the Pacific—but whether it evolves into a history-making event could hinge on fickle winds and other volatile atmospheric shifts.
Something coming: what scientists know about a potential 'super' El Nino
Forecasters say a potentially "super" El Nino is rapidly taking shape in the Pacific -- but whether it evolves into a history-making event could hinge on fickle winds and other volatile atmospheric sh...
James Webb discovers a rare giant planet with surprisingly Earth-like temperatures
Astronomers using NASA’s James Webb Space Telescope have uncovered a rare world unlike anything in our solar system — a giant planet about the size of Saturn with surprisingly Earth-like temperatures and an atmosphere packed with methane. The planet, TOI-199b, sits more than 330 light-years away and is one of the first known “temperate” gas giants ever studied in detail.
Guzman Y Gomez Gives Up on Failing US Business; Shares Soar
(Bloomberg) -- Australian burrito chain Guzman y Gomez Ltd. said it’s closing its Chicago restaurants and exiting the US after failing to generate adequate sales. The company’s shares soared.Most Read from BloombergSpot the Difference: Putin Gets Trump Treatment From Xi in ChinaIran Says the US’s Latest Proposal Has ‘Narrowed the Gaps’Modi’s Toffee Gift to Meloni Ignites Rally in Wrong Indian StockIran in Talks With Oman Over Permanent Hormuz Toll SystemDow Average Climbs to Record on US-Iran De